0001209191-15-039437.txt : 20150506
0001209191-15-039437.hdr.sgml : 20150506
20150506162447
ACCESSION NUMBER: 0001209191-15-039437
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150504
FILED AS OF DATE: 20150506
DATE AS OF CHANGE: 20150506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15837332
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2015-05-04
4
M
0
1125
37.86
A
19500
D
Common Stock
2015-05-04
4
S
0
577
126.15
D
18923
D
Common Stock
2015-05-04
4
S
0
332
127.09
D
18591
D
Common Stock
2015-05-04
4
S
0
216
128.22
D
18375
D
Common Stock
2015-05-05
4
M
0
1687
45.11
A
20062
D
Common Stock
2015-05-05
4
M
0
1289
77.31
A
21351
D
Common Stock
2015-05-05
4
S
0
1676
121.92
D
19675
D
Common Stock
2015-05-05
4
S
0
1000
122.90
D
18675
D
Common Stock
2015-05-05
4
S
0
200
123.85
D
18475
D
Common Stock
2015-05-05
4
S
0
100
125.20
D
18375
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
37.86
2015-05-04
4
M
0
1125
0.00
D
2022-02-01
Common Stock
1125
3375
D
Stock Option (right to buy)
45.11
2015-05-05
4
M
0
1687
0.00
D
2023-02-04
Common Stock
1687
11813
D
Stock Option (right to buy)
77.31
2015-05-05
4
M
0
1289
0.00
D
2024-02-04
Common Stock
1289
14179
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $126.15 (range $125.64 to $126.63).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $127.09 (range $126.87 to $127.40).
Open market sales reported on this line occurred at a weighted average price of $128.22 (range $127.99 to $128.68).
Open market sales reported on this line occurred at a weighted average price of $121.92 (range $121.56 to $122.41).
Open market sales reported on this line occurred at a weighted average price of $122.90 (range $122.58 to $123.33).
Open market sales reported on this line occurred at a weighted average price of $123.85 (range $123.68 to $124.01).
The option vests in 16 quarterly installments from 02/02/2012.
The option vests in 16 quarterly installments from 02/05/2013.
The option vests in 16 quarterly installments from 02/05/2014.
Omar White, Attorney-In-Fact
2015-05-06